Pancreatic cancer vaccine shows some promise
A vaccine for pancreatic cancer in Phase II trials is showing some promise in extending patient's lives according to Reuter's.
Most of the patients who got the vaccine survived at least two years, Dr. Daniel Laheru of Johns Hopkins University in Baltimore and colleagues told a meeting of gastrointestinal cancer specialists.
In the phase II study of 60 patients, 88 percent were alive a year later and 76 percent lived two years.
In comparison, 63 percent of patients treated with surgery alone survive a year and 42 percent live two years.
Interesting, but as nearly as I can tell, this research is actually from November 2005. It looks like it's making news because it was just presented at the 2007 Gastrointestinal Cancers Symposium. Regardless, this is good news. How long until we have a regular bevy of cancer vaccines in our arsenal?
[tags]Medicine, cancer, pancreatic cancer, vaccines[/tags]
No Comments »
No comments yet.
RSS feed for comments on this post.
| TrackBack URI
You can also bookmark
this on del.icio.us or check the cosmos